aluates Reports

$ 0.0

Automative

Global Antisense Oligonucleotides-based Therapeutics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-20D16387

Global Antisense Oligonucleotides based Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Antisense Oligonucleotides-based Therapeutics Market Research Report 2025

Code: QYRE-Auto-20D16387

Report

May 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sarepta Therapeutics

Ionis Pharmaceuticals

Biogen

Nippon Shinyaku

SOBI

Jazz Pharmaceuticals

Antisense Oligonucleotides-based Therapeutics Market Size

The global market for Antisense Oligonucleotides-based Therapeutics was valued at US$ 4149 million in the year 2024 and is projected to reach a revised size of US$ 12520 million by 2031, growing at a CAGR of 17.3% during the forecast period.

Antisense Oligonucleotides-based Therapeutics Market

Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases.

The Antisense Oligonucleotide (ASO) Market is driven by the promising potential of ASOs in treating genetic disorders, rare diseases, and certain cancers by targeting specific RNA molecules and inhibiting their expression. ASOs represent a groundbreaking therapeutic approach that offers the possibility of highly targeted and personalized treatments. As our understanding of genomics and molecular biology advances, and precision medicine gains momentum, the demand for ASOs continues to grow. Innovations in ASO design, chemical modifications, and delivery technologies further contribute to market expansion. However, a significant challenge for this market is the need to address effective delivery to the target tissues, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Overcoming delivery hurdles, minimizing off-target effects, and managing high development costs are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to fully unlock the therapeutic potential of ASOs. Striking a balance between providing safe, effective, and accessible ASO therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Antisense Oligonucleotide (ASO) Market.

This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotides-based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotides-based Therapeutics.

The Antisense Oligonucleotides-based Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense Oligonucleotides-based Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antisense Oligonucleotides-based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antisense Oligonucleotides-based Therapeutics Market Report

Report Metric	Details
Report Name	Antisense Oligonucleotides-based Therapeutics Market
Accounted market size in year	US$ 4149 million
Forecasted market size in 2031	US$ 12520 million
CAGR	17.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	With Chemical Modification Without Chemical Modification
Segment by Application	Neuromuscular Diseases hATTR Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sarepta Therapeutics, Ionis Pharmaceuticals, Biogen, Nippon Shinyaku, Sobi, Jazz Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Oligonucleotides-based Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antisense Oligonucleotides-based Therapeutics Market growing?

Ans: The Antisense Oligonucleotides-based Therapeutics Market witnessing a CAGR of 17.3% during the forecast period 2025-2031.

What is the Antisense Oligonucleotides-based Therapeutics Market size in 2031?

Ans: The Antisense Oligonucleotides-based Therapeutics Market size in 2031 will be US$ 12520 million.

Who are the main players in the Antisense Oligonucleotides-based Therapeutics Market report?

Ans: The main players in the Antisense Oligonucleotides-based Therapeutics Market are Sarepta Therapeutics, Ionis Pharmaceuticals, Biogen, Nippon Shinyaku, Sobi, Jazz Pharmaceuticals

What are the Application segmentation covered in the Antisense Oligonucleotides-based Therapeutics Market report?

Ans: The Applications covered in the Antisense Oligonucleotides-based Therapeutics Market report are Neuromuscular Diseases, hATTR, Other

What are the Type segmentation covered in the Antisense Oligonucleotides-based Therapeutics Market report?

Ans: The Types covered in the Antisense Oligonucleotides-based Therapeutics Market report are With Chemical Modification, Without Chemical Modification

Recommended Reports

Oligonucleotide Therapeutics

RNA Therapeutics

siRNA and Related Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antisense Oligonucleotides-based Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 With Chemical Modification

1.2.3 Without Chemical Modification

1.3 Market by Application

1.3.1 Global Antisense Oligonucleotides-based Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neuromuscular Diseases

1.3.3 hATTR

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antisense Oligonucleotides-based Therapeutics Market Perspective (2020-2031)

2.2 Global Antisense Oligonucleotides-based Therapeutics Growth Trends by Region

2.2.1 Global Antisense Oligonucleotides-based Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antisense Oligonucleotides-based Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Antisense Oligonucleotides-based Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Antisense Oligonucleotides-based Therapeutics Market Dynamics

2.3.1 Antisense Oligonucleotides-based Therapeutics Industry Trends

2.3.2 Antisense Oligonucleotides-based Therapeutics Market Drivers

2.3.3 Antisense Oligonucleotides-based Therapeutics Market Challenges

2.3.4 Antisense Oligonucleotides-based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antisense Oligonucleotides-based Therapeutics Players by Revenue

3.1.1 Global Top Antisense Oligonucleotides-based Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Antisense Oligonucleotides-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antisense Oligonucleotides-based Therapeutics Revenue

3.4 Global Antisense Oligonucleotides-based Therapeutics Market Concentration Ratio

3.4.1 Global Antisense Oligonucleotides-based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides-based Therapeutics Revenue in 2024

3.5 Global Key Players of Antisense Oligonucleotides-based Therapeutics Head office and Area Served

3.6 Global Key Players of Antisense Oligonucleotides-based Therapeutics, Product and Application

3.7 Global Key Players of Antisense Oligonucleotides-based Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antisense Oligonucleotides-based Therapeutics Breakdown Data by Type

4.1 Global Antisense Oligonucleotides-based Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Antisense Oligonucleotides-based Therapeutics Forecasted Market Size by Type (2026-2031)

5 Antisense Oligonucleotides-based Therapeutics Breakdown Data by Application

5.1 Global Antisense Oligonucleotides-based Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Antisense Oligonucleotides-based Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antisense Oligonucleotides-based Therapeutics Market Size (2020-2031)

6.2 North America Antisense Oligonucleotides-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025)

6.4 North America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antisense Oligonucleotides-based Therapeutics Market Size (2020-2031)

7.2 Europe Antisense Oligonucleotides-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025)

7.4 Europe Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antisense Oligonucleotides-based Therapeutics Market Size (2020-2031)

9.2 Latin America Antisense Oligonucleotides-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sarepta Therapeutics

11.1.1 Sarepta Therapeutics Company Details

11.1.2 Sarepta Therapeutics Business Overview

11.1.3 Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Introduction

11.1.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

11.1.5 Sarepta Therapeutics Recent Development

11.2 Ionis Pharmaceuticals

11.2.1 Ionis Pharmaceuticals Company Details

11.2.2 Ionis Pharmaceuticals Business Overview

11.2.3 Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Introduction

11.2.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

11.2.5 Ionis Pharmaceuticals Recent Development

11.3 Biogen

11.3.1 Biogen Company Details

11.3.2 Biogen Business Overview

11.3.3 Biogen Antisense Oligonucleotides-based Therapeutics Introduction

11.3.4 Biogen Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

11.3.5 Biogen Recent Development

11.4 Nippon Shinyaku

11.4.1 Nippon Shinyaku Company Details

11.4.2 Nippon Shinyaku Business Overview

11.4.3 Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Introduction

11.4.4 Nippon Shinyaku Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

11.4.5 Nippon Shinyaku Recent Development

11.5 Sobi

11.5.1 Sobi Company Details

11.5.2 Sobi Business Overview

11.5.3 Sobi Antisense Oligonucleotides-based Therapeutics Introduction

11.5.4 Sobi Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

11.5.5 Sobi Recent Development

11.6 Jazz Pharmaceuticals

11.6.1 Jazz Pharmaceuticals Company Details

11.6.2 Jazz Pharmaceuticals Business Overview

11.6.3 Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Introduction

11.6.4 Jazz Pharmaceuticals Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

11.6.5 Jazz Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sarepta Therapeutics

Ionis Pharmaceuticals

Biogen

Nippon Shinyaku

SOBI

Jazz Pharmaceuticals

List of Tables

Table 1. Global Antisense Oligonucleotides-based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of With Chemical Modification

Table 3. Key Players of Without Chemical Modification

Table 4. Global Antisense Oligonucleotides-based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Antisense Oligonucleotides-based Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Antisense Oligonucleotides-based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Antisense Oligonucleotides-based Therapeutics Market Share by Region (2020-2025)

Table 8. Global Antisense Oligonucleotides-based Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Antisense Oligonucleotides-based Therapeutics Market Share by Region (2026-2031)

Table 10. Antisense Oligonucleotides-based Therapeutics Market Trends

Table 11. Antisense Oligonucleotides-based Therapeutics Market Drivers

Table 12. Antisense Oligonucleotides-based Therapeutics Market Challenges

Table 13. Antisense Oligonucleotides-based Therapeutics Market Restraints

Table 14. Global Antisense Oligonucleotides-based Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Antisense Oligonucleotides-based Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Antisense Oligonucleotides-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides-based Therapeutics as of 2024)

Table 17. Ranking of Global Top Antisense Oligonucleotides-based Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotides-based Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Antisense Oligonucleotides-based Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Antisense Oligonucleotides-based Therapeutics, Product and Application

Table 21. Global Key Players of Antisense Oligonucleotides-based Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antisense Oligonucleotides-based Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Antisense Oligonucleotides-based Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Antisense Oligonucleotides-based Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Antisense Oligonucleotides-based Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Antisense Oligonucleotides-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Antisense Oligonucleotides-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antisense Oligonucleotides-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sarepta Therapeutics Company Details

Table 47. Sarepta Therapeutics Business Overview

Table 48. Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Product

Table 49. Sarepta Therapeutics Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Sarepta Therapeutics Recent Development

Table 51. Ionis Pharmaceuticals Company Details

Table 52. Ionis Pharmaceuticals Business Overview

Table 53. Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product

Table 54. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Ionis Pharmaceuticals Recent Development

Table 56. Biogen Company Details

Table 57. Biogen Business Overview

Table 58. Biogen Antisense Oligonucleotides-based Therapeutics Product

Table 59. Biogen Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Biogen Recent Development

Table 61. Nippon Shinyaku Company Details

Table 62. Nippon Shinyaku Business Overview

Table 63. Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Product

Table 64. Nippon Shinyaku Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Nippon Shinyaku Recent Development

Table 66. Sobi Company Details

Table 67. Sobi Business Overview

Table 68. Sobi Antisense Oligonucleotides-based Therapeutics Product

Table 69. Sobi Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Sobi Recent Development

Table 71. Jazz Pharmaceuticals Company Details

Table 72. Jazz Pharmaceuticals Business Overview

Table 73. Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product

Table 74. Jazz Pharmaceuticals Revenue in Antisense Oligonucleotides-based Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Jazz Pharmaceuticals Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Antisense Oligonucleotides-based Therapeutics Picture

Figure 2. Global Antisense Oligonucleotides-based Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antisense Oligonucleotides-based Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. With Chemical Modification Features

Figure 5. Without Chemical Modification Features

Figure 6. Global Antisense Oligonucleotides-based Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Antisense Oligonucleotides-based Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Neuromuscular Diseases Case Studies

Figure 9. hATTR Case Studies

Figure 10. Other Case Studies

Figure 11. Antisense Oligonucleotides-based Therapeutics Report Years Considered

Figure 12. Global Antisense Oligonucleotides-based Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Antisense Oligonucleotides-based Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Antisense Oligonucleotides-based Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Antisense Oligonucleotides-based Therapeutics Market Share by Players in 2024

Figure 16. Global Top Antisense Oligonucleotides-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides-based Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Antisense Oligonucleotides-based Therapeutics Revenue in 2024

Figure 18. North America Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Antisense Oligonucleotides-based Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Antisense Oligonucleotides-based Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Antisense Oligonucleotides-based Therapeutics Market Share by Region (2020-2031)

Figure 32. China Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Antisense Oligonucleotides-based Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Antisense Oligonucleotides-based Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Antisense Oligonucleotides-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

Figure 48. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

Figure 49. Biogen Revenue Growth Rate in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

Figure 50. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

Figure 51. Sobi Revenue Growth Rate in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

Figure 52. Jazz Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides-based Therapeutics Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global ASO based Drug Market Research Report 2024

Global Antisense ODN Market Research Report 2024

Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024

Global Antisense Oligonucleotides Market Research Report 2024

Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024

Global Antisense Oligonucleotide Service Market Research Report 2025

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Drugs Market Research Report 2025

Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024

Global Oligonucleotide Therapeutics Market Research Report 2024

Global CNS Specific Antisense Oligonucleotides Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Global Oligonucleotide Drugs ONs Market Research Report 2025

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA based Therapeutics Drug Market Research Report 2024

Global Nucleic acid based Therapeutics Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions